IRIS
ZANOTTI, Ilaria
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 7.512
AS - Asia 6.073
EU - Europa 5.204
SA - Sud America 883
AF - Africa 351
Continente sconosciuto - Info sul continente non disponibili 275
OC - Oceania 3
Totale 20.301
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 7.302
SG - Singapore 2.183
CN - Cina 1.689
IT - Italia 1.559
VN - Vietnam 918
IE - Irlanda 699
BR - Brasile 666
SE - Svezia 612
FI - Finlandia 574
DE - Germania 478
HK - Hong Kong 444
UA - Ucraina 408
ZA - Sudafrica 281
FR - Francia 221
NL - Olanda 192
TR - Turchia 179
BD - Bangladesh 173
GB - Regno Unito 160
CA - Canada 113
RU - Federazione Russa 101
IN - India 100
AR - Argentina 78
KR - Corea 68
IQ - Iraq 49
JP - Giappone 46
ID - Indonesia 43
MX - Messico 42
CO - Colombia 41
AT - Austria 40
BE - Belgio 32
EC - Ecuador 29
ES - Italia 26
PH - Filippine 26
VE - Venezuela 26
PL - Polonia 21
PK - Pakistan 20
CZ - Repubblica Ceca 19
CI - Costa d'Avorio 16
JM - Giamaica 15
TH - Thailandia 15
JO - Giordania 14
CL - Cile 13
UZ - Uzbekistan 13
IR - Iran 11
PY - Paraguay 11
UY - Uruguay 11
MA - Marocco 10
AE - Emirati Arabi Uniti 9
EU - Europa 9
MY - Malesia 9
SA - Arabia Saudita 9
KE - Kenya 8
TW - Taiwan 8
CH - Svizzera 7
EG - Egitto 7
KZ - Kazakistan 7
LT - Lituania 7
PA - Panama 7
AL - Albania 6
AZ - Azerbaigian 6
CR - Costa Rica 6
NP - Nepal 6
OM - Oman 6
TN - Tunisia 6
BO - Bolivia 5
HN - Honduras 5
RO - Romania 5
RS - Serbia 5
BA - Bosnia-Erzegovina 4
BB - Barbados 4
DZ - Algeria 4
HU - Ungheria 4
LB - Libano 4
SV - El Salvador 4
TT - Trinidad e Tobago 4
AU - Australia 3
BY - Bielorussia 3
CM - Camerun 3
GT - Guatemala 3
LY - Libia 3
MD - Moldavia 3
PS - Palestinian Territory 3
QA - Qatar 3
SK - Slovacchia (Repubblica Slovacca) 3
SN - Senegal 3
AM - Armenia 2
AO - Angola 2
BG - Bulgaria 2
BH - Bahrain 2
EE - Estonia 2
GA - Gabon 2
GR - Grecia 2
KG - Kirghizistan 2
LU - Lussemburgo 2
MU - Mauritius 2
NO - Norvegia 2
PE - Perù 2
PR - Porto Rico 2
SY - Repubblica araba siriana 2
BN - Brunei Darussalam 1
Totale 20.017
Salva come PNG Salva come JPEG
Città #
Singapore 1.063
San Jose 819
Ashburn 772
Dublin 697
Chandler 607
Santa Clara 556
Beijing 485
Jacksonville 445
Hong Kong 417
Parma 360
Dallas 322
Ho Chi Minh City 294
Council Bluffs 284
Johannesburg 267
Ann Arbor 238
New York 215
Dearborn 210
Boardman 206
Hanoi 199
Nanjing 160
Princeton 140
Izmir 139
Milan 137
Los Angeles 130
Hefei 127
Lauterbourg 127
Wilmington 96
Chicago 92
Bologna 88
Bremen 87
San Mateo 85
Shanghai 85
Munich 74
Toronto 70
São Paulo 68
Helsinki 64
Shenyang 63
Seoul 58
Moscow 57
Rome 56
Buffalo 51
Nanchang 46
Kunming 42
Des Moines 40
Jinan 40
Columbus 39
Haiphong 39
Hebei 39
Modena 39
Da Nang 37
Woodbridge 35
Grafing 33
Houston 33
Seattle 33
Tianjin 33
Vienna 33
Brussels 30
Orem 29
Jiaxing 28
Marseille 25
Changsha 24
Guangzhou 24
Brooklyn 23
Jakarta 23
Belo Horizonte 22
Hangzhou 22
Phoenix 22
Istanbul 21
Turku 21
The Dalles 20
Turin 20
Frankfurt am Main 19
Hải Dương 19
Tokyo 19
Zhengzhou 18
Atlanta 17
Baghdad 17
Bogotá 17
London 17
Nuremberg 17
Washington 17
Abidjan 16
Brasília 16
Montreal 16
Reggio Emilia 16
Rio de Janeiro 16
Bergamo 15
Chennai 15
Curitiba 15
Hillsboro 15
Norwalk 15
San Francisco 15
Amman 14
Bari 14
Bengaluru 14
Naples 14
Taiyuan 14
Thái Nguyên 14
Warsaw 14
Biên Hòa 13
Totale 11.883
Salva come PNG Salva come JPEG
Nome #
Principi di farmacognosia e fitoterapia. Seconda edizione 802
A New ABCB1 Inhibitor Enhances the Anticancer Effect of Doxorubicin in Both In Vitro and In Vivo Models of NSCLC 312
PCSK9 ablation attenuates Aβ pathology, neuroinflammation and cognitive dysfunctions in 5XFAD mice 263
Identification of 4-amino-2-Pyridones as new potent PCSK9 inhibitors: From phenotypic hit discovery to in vivo tolerability 246
The adaptation of lipid profile of human fibroblasts to alginate 2D films and 3D printed scaffolds 244
Three-Dimensional (3D) Printed Silver Nanoparticles/Alginate/Nanocrystalline Cellulose Hydrogels: Study of the Antimicrobial and Cytotoxicity Efficacy 241
Combining ligand- and structure-based approaches for the discovery of new inhibitors of the EPHA2-ephrin-A1 interaction 212
UniPR129 is a competitive small molecule Eph-ephrin antagonist blocking in vitro angiogenesis at low micromolar concentrations. 209
Atheroprotective effects of (poly)phenols: focus on cell cholesterol metabolism 193
A Short Term Administration of Cyclosporine A to Mice Inhibits the Reverse Cholesterol Transport from Macrophages 185
Antiatherogenic effects of ellagic acid and urolithins in vitro 183
Increased PCSK9 Cerebrospinal Fluid Concentrations in Alzheimer's Disease 178
Rationale and design of the expanded combination of evolocumab plus empagliflozin in diabetes: EXCEED-BHS3 trial 176
A unique protease-sensitive high density lipoprotein particle containing the apolipoprotein A-I(Milano) dimer effectively promotes ATP-binding Cassette A1-mediated cell cholesterol efflux 175
Attivita' del Probucolo nell'inibire l'efflusso lipidico cellulare ABCA1-mediato 175
Polyphenol health effects on cardiovascular and neurodegenerative disorders: A review and meta-analysis 173
Alcohol pattern consumption differently affects the efficiency of macrophage reverse cholesterol transport in vivo 173
PROPROTEIN CONVERTASE SUBTILISIN/KEXIN TYPE 9 (PCSK9) GENETIC DELETION ATTENUATES AMYLOID-. PATHOLOGY, NEUROINFLAMMATION AND IMPROVES COGNITIVE FUNCTIONS IN AN ALZHEIMER'S DISEASE MOUSE MODEL 170
CYCLOSPORINE A IMPAIRS THE REVERSE CHOLESTEROL TRANSPORT FROM MACROPHAGES IN VIVO BY REDUCING STEROL FECAL EXCRETION 170
Effetto delle statine sull’efflusso ABCA1 in macrofagi e cellule epatiche 169
Cholesterol efflux and reverse cholesterol transport 165
Macrophage, But Not Systemic, Apolipoprotein E Is Necessary for Macrophage Reverse Cholesterol Transport In Vivo 164
Dietary Ellagitannin Metabolites Exert Antiatherosclerotic Effects in Vitro 163
The Gut Microbial Metabolite Trimethylamine-N-Oxide Is Present in Human Cerebrospinal Fluid 163
High-Density Lipoproteins at the Interface between the NLRP3 Inflammasome and Myocardial Infarction 161
Ruolo dell’apolipoproteine E nell’efflusso cellulare di colesterolo 161
Opposite effects of moderate and excess alcohol consumption on the atheroprotective process of the reverse cholesterol transport in vivo 161
Δ5-Cholenoyl-amino acids as selective and orally available antagonists of the Eph-ephrin system 158
Abnormal splicing of ABCA1 pre-mRNA in Tangier disease due to a IVS2+5G>C mutation in ABCA1 gene 157
Cyclosporine A Impairs the Macrophage Reverse Cholesterol Transport in Mice by Reducing Sterol Fecal Excretion 155
Evidence for cholesterol-lowering activity by Bifidobacterium bifidum PRL2010 through gut microbiota modulation. 154
Cholesterol efflux promoting function of high-density lipoproteins in calcific aortic valve stenosis 154
Probucol inhibits ABCA1-mediated cellular lipids efflux 153
Cellular cholesterol efflux pathways: Impact on Intracellular Lipid Trafficking and Methodological Considerations 153
Recettori LXR e trasporto inverso del colesterolo 153
CYCLOSPORINE A IMPAIRS THE REVERSE CHOLESTEROL TRANSPORT FROM MACROPHAGES IN VIVO BY REDUCING STEROL FECAL EXCRETION 153
Cyclosporine A modulates the macrophage reverse cholesterol transport in vivo 152
Effects of moderate and excess alcohol consumption on the reverse cholesterol transport in vivo 151
Metadynamics for perspective drug design: Computationally driven synthesis of new protein-protein interaction inhibitors targeting the EphA2 receptor 151
Role of Apolipoprotein E in cellular cholesterol efflux 150
HDL and reverse cholesterol transport in humans and animals: Lessons from pre-clinical models and clinical studies 149
Approccio nutraceutico al rischio cardiovascolare residuo 148
Effetto della Ciclosporina A sul trasporto inverso del colesterolo in vivo 148
LA CICLOSPORINA A RIDUCE IL TRASPORTO INVERSO DEL COLESTEROLO NEI TOPI ATTRAVERSO L’INIBIZIONE DELL’ESCREZIONE FECALE 148
LA CICLOSPORINA A INIBISCE IL TRASPORTO INVERSO DEL COLESTEROLO NEI TOPI 147
Increased PCSK9 cerebrospinal fluid concentrations in Alzheimer’s disease 147
A SHORT TERM ADMINISTRATION OF CYCLOSPORINE A IMPAIRS THE REVERSE CHOLESTEROL TRANSPORT FROM MACROPHAGES IN VIVO 145
Dysfunctional high-density lipoproteins in type 2 diabetes mellitus: Molecular mechanisms and therapeutic implications 145
CHOLESTEROL EFFLUX CAPACITY, HDL-C LEVELS AND CORONARY CALCIUM SCORE AMONG THE VERY ELDERLY SUBJECTS 143
Lercanidipine Reduces Free Cholesterol-Induced Cytotoxicity 143
Apparato cardiovascolare 142
Analysis of lipid efflux in fibroblasts from Niemann Pick Type C disease subjects 142
Impaired ATP-binding cassette transporter A1-mediated sterol efflux from oxidized LDL-loaded macrophages 141
Effect of carvedilol on cholesterol esterification and nitric oxide synthesis in cultured macrophages 140
Cyclosporine a affects the reverse cholesterol transport from macrophages in vivo 139
Effetto degli agonisti LXR sul trasporto inverso del colesterolo in vivo 138
Pitavastatin increases ABCA1-mediated lipid efflux from Fu5AH rat hepatoma cells 135
A BENZODIAZEPINE ANALOGUE PROMOTES FAECAL STEROL EXCRETION IN APOA-I OVEREXPRESSING MICE 134
Cholesterol efflux capacity does not associate with coronary calcium, plaque vulnerability and telomere length in healthy octogenarians 134
Anti-Atherosclerotic Effect of a Polyphenol-Rich Ingredient, Oleactiv®, in a Hypercholesterolemia-Induced Golden Syrian Hamster Model 134
RUOLO DELLA SFINGOSINA 1-FOSFATO E DEL SUO RECETTORE S1P3 NEL TRASPORTO INVERSO DEL COLESTEROLO 132
Pitavastatin Differently Modulates ATP Binding Cassette A1-Mediated Lipid Efflux in Macrophages and Hepatic Cells 130
Recombinant Alpha-1 Antitrypsin as Dry Powder for Pulmonary Administration: A Formulative Proof of Concept 129
ROLE OF APOLIPOPROTEIN E IN CELLULAR CHOLESTEROL EFFLUX 129
Distant homology modeling of LCAT and its validation through in silico targeting and in vitro and in vivo assays. 129
Phenyl-γ-valerolactones, flavan-3-ol colonic metabolites, protect brown adipocytes from oxidative stress without affecting their differentiation or function 129
Modulazione dell'omeostasi del colesterolo da parte di proprotein convertase subtilisin/kexin type 9 (PCSK9) nel macrofago 128
ATTIVITA’ IPOLIPIDEMIZZANTE DEL NUTRACEUTICO OLEACTIV® NEL MODELLO DEL CRICETO GOLDEN SYRIAN 128
The rare bile acid isoallolithocholic acid (IALCA) is an EphA2 antagonist sparing FXR and TGR5 receptors 127
Probucol Inhibition of ATP-Binding Cassette A1-Mediated Cellular Lipid Efflux 127
TRASPORTO INVERSO DEL COLESTEROLO: FATTORI DETERMINANTI L’EFFICIENZA DEL PROCESSO 126
Impaired ATP-binding cassette Transporter AI-mediated Sterols Efflux from Oxidized LDL Loaded Macrophages 125
Dual effect of statins on ABCA1-mediated lipid efflux from macrophages and hepatic cells 125
The LXR agonist T0901317 promotes the reverse cholesterol transport frommacrophages by increasing plasma efflux potential 125
Fu5AH express functional ABCA1 upon treatment with 22OH-cholesterol and cis-9 retinoic acid 124
Macrophage, but not systemic, apolipoprotein E is necessary for macrophage reverse cholesterol transport in vivo 123
Effect of carvedilol on cholesterol esterification and nitric oxide synthesis in cultured macrophages 123
Probucol inhibition of ABCA1-mediated cellular lipid efflux 122
IN VIVO TREATMENT WITH CYCLOSPORINE A INCREASES EFFLUX POTENTIAL OF MOUSE PLASMA VIA ATP-BINDING CASSETTE TRANSPORTER ABCA1 122
La Lercanidipina riduce la tossicita' cellulare indotta dall'accumulo di colesterolo libero 120
Dual effect of statins on ABCA1-mediated lipid efflux from macrophages and hepatic cells 120
Impact of dietary lipids on the reverse cholesterol transport: What we learned from animal studies 119
Therapeutic perspectives of Eph–ephrin system modulation 118
Relative Contributions of ABCA1 and SR-BI to Cholesterol Efflux to Serum From Fibroblasts and Macrophages 117
Pitavastatin Differently Modulates ABCA1-Mediated Lipid Efflux in Macrophages and Hepatic Cells 117
Effect of HDL composition and size on cellular cholesterol efflux 117
Increased ABCA1-mediated cholesterol efflux potential of sera from ApoAI milano carriers 116
Effect of apoA-I overexpression on “in vivo” reverse cholesterol transport from macrophages 116
Cholesterol efflux from oxidized LDL loaded macrophages 116
Fu5AH cells express functional ABCA1 upon treatment with 22OH-cholesterol and cis-9 retinoic acid 115
Increased ABCA1-mediated cholesterol efflux potential of sera from ApoAImilano carriers 115
ROLE OF APOLIPOPROTEIN E IN THE REVERSE CHOLESTEROL TRANSPORT IN VIVO 114
CHOLESTEROL EFFLUX CAPACITY, HDL-C LEVELS AND CORONARY CALCIUM SCORE AMONG THE VERY ELDERLY SUBJECTS 114
THE THIENOTRIAZOLODIAZEPINE RO 11-1464 INCREASES PLASMA APOA-I AND PROMOTES REVERSE CHOLESTEROL TRANSPORT AND FECAL STEROL EXCRETION IN HUMAN APOA-I TRANSGENIC MICE 114
Investigation on mechanisms of cholesterol efflux in human monocytes/macrophages THP-1 113
Microbiota intestinale: un nuovo protagonista nella eziologia e nel trattamento dell'aterosclerosi? 113
Impact of apolipoprotein E (apoE) deficiency on reverse cholesterol transport in vivo 112
Impaired ATP-binding Cassette Transporter AI-mediated sterol efflux from oxidized LDL loaded macrophages 111
Modulation of cholesterol efflux in human THP-I macrophages 109
PROPROTEIN CONVERTASE SUBTILISIN/KEXIN TYPE 9 INHIBITS ATP BINDING CASSETTE TRANSPORTER A1-MEDIATED CHOLESTEROL EFFLUX FROM MACROPHAGES 108
Totale 15.440
Salva come PNG Salva come JPEG
Categoria #
all - tutte 68.868
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 68.868
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022653 0 0 0 41 24 64 67 92 39 55 39 232
2022/20232.534 293 242 158 175 244 273 36 127 862 32 72 20
2023/20241.094 45 88 17 43 63 285 76 80 54 78 71 194
2024/20253.411 93 171 254 246 360 347 100 153 476 318 277 616
2025/20267.280 648 695 790 573 979 330 987 300 776 612 326 264
2026/20271.272 251 376 413 232 0 0 0 0 0 0 0 0
Totale 20.301